Found: 7
Select item for more details and to access through your institution.
The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.868579
- By:
- Publication type:
- Article
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.
- Published in:
- Scientific Reports, 2015, p. 1, doi. 10.1038/srep14746
- By:
- Publication type:
- Article
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1345363
- By:
- Publication type:
- Article
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub>and G<sub>q/11</sub>.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.02200
- By:
- Publication type:
- Article
Identification and pharmacological characterization of succinate receptor agonists.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 6, p. 613, doi. 10.3390/cells8060613
- By:
- Publication type:
- Article
GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G<sub>s</sub> and G<sub>q/11</sub>.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18500-x
- By:
- Publication type:
- Article